Skip to content

The Study of the role of gamma delta T cells in lung cancer

Application of gamma delta T cells in cancer immunotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029102
Enrollment
Unknown
Registered
2020-01-13
Start date
2019-10-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Lung cancer tissue group :NO
Paracancerous tissue group of lung cancer :NO

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. From October 2019 to March 2020, the patients were operated in our hospital; 2. The tumor was removed by operation and the adjacent tissue was retained; 3. Patients between 18 and 65 years old, regardless of gender; 4. Patients with non-small cell lung cancer were diagnosed by rapid intraoperative examination and postoperative pathology; 5. There was no other malignant tumor outside the lung; 6. No radiotherapy, chemotherapy and immunotherapy were performed before operation; 7. The clinical records were complete include (1) ECG; (2) blood, urine and stool routine; (3) biochemical complete set; (4) tumor markers; (5) chest and abdomen CT examination); 8. Patients or immediate family members voluntarily sign informed consent after knowing the details of the study; 9. No other organ diseases were found.

Exclusion criteria

Exclusion criteria: 1. Patients suspected of lung cancer by intraoperative rapid disease examination need definite diagnosis of large pathological tissues after operation; 2. Patients with pulmonary tuberculosis, benign tumor and mediastinal lymphoma; 3. Patients with severe impairment of heart, liver and kidney function or severe respiratory insufficiency; 4. Mental illness and speech dysfunction.

Design outcomes

Primary

MeasureTime frame
gamma delta T cell;

Countries

China

Contacts

Public ContactLei Shen

Renmin Hospital of Wuhan University

leishenwuhan@126.com+86 13886066636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026